Published in Infect Immun on February 01, 1972
The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. Br J Cancer (1979) 1.82
Photodynamic therapy for localized infections--state of the art. Photodiagnosis Photodyn Ther (2009) 1.73
Photodynamic therapy for infections: clinical applications. Lasers Surg Med (2011) 1.42
Early events in herpes simplex virus type 1 infection: photosensitivity of fluorescein isothiocyanate-treated virions. Proc Natl Acad Sci U S A (1981) 1.29
Comparison of the treatment of herpes genitalis in men with proflavine photoinactivation, idoxuridine ointment, and normal saline. Br J Vener Dis (1975) 1.06
Neutral red with photoinactivation in the treatment of herpes genitalis. Br J Vener Dis (1975) 1.01
Herpesvirus hominis type 2 infections in rabbits: effect of prior immunization with attenuated Mycobacterium bovis (BCG) cells. Infect Immun (1972) 1.00
The latent herpes simplex virus. Bacteriol Rev (1974) 1.00
Proflavine and light in the treatment of experimental herpetic ocular infections. Antimicrob Agents Chemother (1974) 0.99
Photodynamic inactivation with proflavine: quantitative comparison with iodo-deoxyuridine. Infect Immun (1973) 0.98
Antiviral activity of 10-carboxymethyl-9-acridanone. Antimicrob Agents Chemother (1976) 0.89
Miconazole nitrate compared with chlordantoin in the treatment of vaginal candidiasis. Br J Vener Dis (1975) 0.83
The role of mitochondrial DNA damage in the citotoxicity of reactive oxygen species. J Bioenerg Biomembr (2011) 0.82
Photodynamic therapy induces an immune response against a bacterial pathogen. Expert Rev Clin Immunol (2012) 0.82
Antiviral therapy. Yale J Biol Med (1978) 0.81
Photoinactivation of latent herpes simplex virus in rabbit kidney cells. Antimicrob Agents Chemother (1976) 0.77
Impact of photodynamic inactivation (PDI) using the photosensitizer chlorin e6 on viability, apoptosis, and proliferation of human keratocytes in vitro. Graefes Arch Clin Exp Ophthalmol (2013) 0.76
Effect of Photodynamic Therapy on the Virulence Factors of Staphylococcus aureus. Front Microbiol (2016) 0.76
PHOTODYNAMIC INACTIVATION OF POLIOVIRUS. Virology (1963) 2.92
Photodynamic inactivation of animal viruses: a review. Photochem Photobiol (1966) 1.80
IRREVERSIBLE PHOTOSENSITIZATION OF VIRUSES. Virology (1964) 1.72
Inactivation of viruses by the photodynamic action of toluidine blue. J Immunol (1960) 1.51
PHOTODYNAMIC INACTIVATION OF ENTEROVIRUSES. J Bacteriol (1965) 0.97
INFLUENZA VACCINE PREPARED BY PHOTODYNAMIC INACTIVATION OF VIRUS. J Immunol (1963) 0.90
Inherent photosensitivity of herpes virus and other enveloped viruses. J Gen Virol (1969) 0.90
Photodynamically inactivated vaccines prepared by growing viruses in cells containing neutral red. J Immunol (1967) 0.88
Florenal in treatment of herpesvirus and adenovirus eye diseases. Invest Ophthalmol (1971) 0.88
Ocular herpes simplex. Invest Ophthalmol (1971) 0.87
Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci U S A (1977) 14.34
Enterovirus concentration on cellulose membranes. Appl Microbiol (1972) 11.78
Concentration of enteroviruses from large volumes of water. Appl Microbiol (1973) 11.43
Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev (1999) 11.32
Concentration of enteroviruses on membrane filters. J Virol (1967) 9.95
Concentration of viruses from sewage by adsorption on millipore membranes. Bull World Health Organ (1967) 7.73
Concentration of viruses from large volumes of tap water using pleated membrane filters. Appl Environ Microbiol (1976) 6.36
Concentration and purification of viruses by adsorption to and elution from insoluble polyelectrolytes. Appl Microbiol (1971) 5.71
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet (2002) 5.48
Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A (1994) 5.00
Rapid isolation of bacteria from septicemic patients by use of an antimicrobial agent removal device. J Clin Microbiol (1980) 4.52
Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 42 enteroviruses. Bull World Health Organ (1973) 4.27
Virus aggregation as the cause of the non-neutralizable persistent fraction. J Virol (1967) 4.25
Preparation of antiserum to enteroviruses in large animals. J Immunol (1965) 4.20
Concentration of viruses on aluminum and calcium salts. Am J Epidemiol (1967) 4.19
Concentration of viruses from sewage and excreta on insoluble polyelectrolytes. Appl Microbiol (1969) 4.17
Concentration of enteroviruses from large volumes of tap water, treated sewage, and seawater. Appl Environ Microbiol (1978) 4.01
Virus movement in soil columns flooded with secondary sewage effluent. Appl Environ Microbiol (1976) 3.99
Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA (2001) 3.91
THE ISOLATION OF POLIOMYELITIS VIRUS FROM HUMAN EXTRA-NEURAL SOURCES. III. PERSISTENCE OF VIRUS IN STOOLS AFTER ACUTE INFECTION. J Clin Invest (1946) 3.88
THE DETECTION OF POLIOMYELITIS VIRUS IN FLIES. Science (1941) 3.81
c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J (1999) 3.65
Structure and Composition of a Small Particle Prepared from a Simian Adenovirus. J Bacteriol (1965) 3.54
Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol (1968) 3.29
Virus isolations from sewage and from a stream receiving effluents of sewage treatment plants. Bull World Health Organ (1970) 3.27
THE ISOLATION OF POLIOMYELITIS VIRUS FROM HUMAN EXTRA-NEURAL SOURCES. IV. SEARCH FOR VIRUS IN THE BLOOD OF PATIENTS. J Clin Invest (1946) 3.25
Physical assay and growth cycle studies of a defective adeno-satellite virus. J Virol (1967) 3.15
The infectivity of adenovirus 5 DNA-protein complex. Virology (1976) 3.12
Virus and bacteria removal from wastewater by land treatment. Appl Environ Microbiol (1976) 3.10
Environmental factors influencing isolation of enteroviruses from polluted surface waters. Appl Microbiol (1974) 3.06
POLIOMYELITIS VIRUS IN FLY-CONTAMINATED FOOD COLLECTED AT AN EPIDEMIC. Science (1945) 3.04
Herpesvirus type 2: association with carcinoma of the cervix. Science (1968) 3.03
Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature (1982) 3.01
Role of sediment in the persistence of enteroviruses in the estuarine environment. Appl Environ Microbiol (1978) 2.99
A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties. Am J Epidemiol (1968) 2.92
WHO collaborative studies on enterovirus reference antisera. Bull World Health Organ (1965) 2.82
Plus and minus single-stranded DNA separately encapsidated in adeno-associated satellite virions. Science (1969) 2.76
The association of herpesvirus type 2 and carcinoma of the uterine cervix. Am J Epidemiol (1969) 2.74
Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation (1996) 2.64
Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry (1992) 2.60
5-Hydroxytryptamine stimulates inositol phosphate production in a cell-free system from blowfly salivary glands. Evidence for a role of GTP in coupling receptor activation to phosphoinositide breakdown. J Biol Chem (1985) 2.60
Type C viruses of baboons: isolation from normal cell cultures. Cell (1974) 2.55
Mitochondrial DNA in yeast and some mammalian species. Science (1966) 2.53
Colorimetric method for rapid determination of bacteriuria. J Clin Microbiol (1981) 2.51
Measurement of antibodies to herpesvirus types 1 and 2 in human sera. J Immunol (1970) 2.45
Enzyme induction in SV40-infected green monkey kidney cultures. Virology (1966) 2.45
Small deoxyribonucleic acid-containing viruses (picodnavirus group). Nature (1966) 2.45
Enhanced detection of Australia antigen in serum hepatitis patients by discontinuous counter-immunoelectrophoresis. Appl Microbiol (1971) 2.44
Evidence for extraterrestrial amino-acids and hydrocarbons in the Murchison meteorite. Nature (1970) 2.41
Wastewater renovation and reuse: virus removal by soil filtration. Science (1976) 2.37
Effects of pancreatin on the growth of reovirus. J Bacteriol (1966) 2.35
The trouble with cognitive subtraction. Neuroimage (1996) 2.35
Development of a quantitative method for detecting enteroviruses in estuarine sediments. Appl Environ Microbiol (1977) 2.35
Separation of factors required for cleavage and polyadenylation of yeast pre-mRNA. Mol Cell Biol (1992) 2.34
Detection of hepatitis A viral antigen by radioimmunoassay. J Immunol (1975) 2.33
Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med (1990) 2.32
Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization. Vaccine (1993) 2.30
Enterovirus type 70: the etiologic agent of pandemic acute haemorrhagic conjunctivitis. Bull World Health Organ (1973) 2.29
SV40-adenovirus "hybrid" populations: transfer of SV40 determinants from one type of adenovirus to another. Proc Natl Acad Sci U S A (1965) 2.27
Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci U S A (1985) 2.26
Occurrence and distribution of bacterial indicators and pathogens in canal communities along the Texas coast. Appl Environ Microbiol (1977) 2.26
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet (2000) 2.26
Concentration of enteroviruses from estuarine water. Appl Environ Microbiol (1977) 2.22
Concentration and purification of influenza virus on insoluble polyelectrolytes. Appl Microbiol (1972) 2.20
Human enteroviruses in oysters and their overlying waters. Appl Environ Microbiol (1979) 2.20
Viral hepatitis. Clinical and tissue culture studies. JAMA (1970) 2.20
Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax (2002) 2.17
Screening blood donations for HCV. Lancet (1992) 2.17
WHO collaborative study on the sero-epidemiology of rubella. Bull World Health Organ (1967) 2.17
Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol (2004) 2.16
WHO collaborative studies on enterovirus reference antisera. Third report. Bull World Health Organ (1970) 2.15
Environmental virology: from detection of virus in sewage and water by isolation to identification by molecular biology--a trip of over 50 years. Annu Rev Microbiol (1995) 2.13
Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet (1983) 2.13
Physicochemical characterization of adeno-associated satellite virus type 4 and its nucleic acid. J Virol (1967) 2.10
Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Intern Med (1984) 2.10
Viruses in water. Bull World Health Organ (1978) 2.10
Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss. Am J Transplant (2014) 2.09